{"disease":{"id":"antiplatelet-therapy","name":"antiplatelet therapy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03338335","title":"Ethnic Differences and the Ischemia/Bleeding Risk of DAPT Duration","phase":"","overall_status":"UNKNOWN","enrollment_count":16000,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT03758248","title":"The Influence of Gene Polymorphism on Clinical Outcomes in Patients Undergoing PCI","phase":"","overall_status":"UNKNOWN","enrollment_count":12000,"lead_sponsor_name":"Beijing Anzhen Hospital","has_results":false},{"nct_id":"NCT06648720","title":"Efficacy and Safety of Shortening Dual Antiplatelet Therapy Duration with IVUS Guidance in PCI Patients","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":3566,"lead_sponsor_name":"University Medical Center Ho Chi Minh City (UMC)","has_results":false},{"nct_id":"NCT06014060","title":"24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A Prospective, Multicenter, Double-Blind, Placebo-Controlled Randomized Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":3300,"lead_sponsor_name":"China National Center for Cardiovascular Diseases","has_results":false},{"nct_id":"NCT05380063","title":"Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":2300,"lead_sponsor_name":"China National Center for Cardiovascular Diseases","has_results":false},{"nct_id":"NCT05491200","title":"Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":1656,"lead_sponsor_name":"Research Maatschap Cardiologen Rotterdam Zuid","has_results":false},{"nct_id":"NCT03525145","title":"Platelet Reactivity And Clinical ThrombotIC Events Study","phase":"","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"Shenyang Northern Hospital","has_results":false},{"nct_id":"NCT07398001","title":"Discontinuation of Antiplatelet Therapy After Drug-Coated Balloon Treatment","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1042,"lead_sponsor_name":"Ulsan University Hospital","has_results":false},{"nct_id":"NCT06075433","title":"Efficacy and Safety of 1-year Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease According to the Complex Higher-risk Procedure","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Genoss Co., Ltd.","has_results":false},{"nct_id":"NCT06075420","title":"Efficacy and Safety of Short Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Genoss Co., Ltd.","has_results":false},{"nct_id":"NCT06535568","title":"Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)","phase":"NA","overall_status":"RECRUITING","enrollment_count":576,"lead_sponsor_name":"Fondazione Ricerca e Innovazione Cardiovascolare ETS","has_results":false},{"nct_id":"NCT05554822","title":"Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":574,"lead_sponsor_name":"Azienda Ospedaliero Universitaria Maggiore della Carita","has_results":false},{"nct_id":"NCT03987373","title":"DACAB Trial: Follow-up Extension","phase":"","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT07299994","title":"Efficacy and Safety of Intravenous Thrombolysis in Branch Atheromatous Disease","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":462,"lead_sponsor_name":"Sigmund Freud PrivatUniversitat","has_results":false},{"nct_id":"NCT06007222","title":"Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"OCEAN-SHD Study Group","has_results":false},{"nct_id":"NCT04824911","title":"Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":376,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT02101411","title":"Platelet Reactivity (High On-Treatment Platelet Reactivity) as Guidance for APT (Antiplatelet Therapy) Adjustment After PCI (Percutaneous Coronary Intervention)","phase":"","overall_status":"COMPLETED","enrollment_count":334,"lead_sponsor_name":"Taipei City Hospital","has_results":true},{"nct_id":"NCT06981390","title":"Ticagrelor-Based Dual Antiplatelet Therapy Duration in CABG","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Kexiang Liu, MD","has_results":false},{"nct_id":"NCT04624295","title":"Early Antiplatelet Therapy After Hemorrhagic Infarction in Acute Ischemic Stroke Treated With Intravenous Thrombolysis (HITs)","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":294,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT04060914","title":"LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":225,"lead_sponsor_name":"Beijing Anzhen Hospital","has_results":false},{"nct_id":"NCT06698874","title":"MCE Identifying Bleeding Lesions in Patients with Antiplatelet Drugs-Related Acute Non-Hematochezia Gastrointestinal Bleeding","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":204,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT05903976","title":"De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Azienda Ospedaliera Universitaria Policlinico \"G. Martino\"","has_results":false},{"nct_id":"NCT06710262","title":"T-TAS® wS Method Comparison","phase":"","overall_status":"COMPLETED","enrollment_count":115,"lead_sponsor_name":"Hikari Dx, Inc.","has_results":false},{"nct_id":"NCT03039205","title":"Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"University of Sao Paulo","has_results":false},{"nct_id":"NCT06339021","title":"OCT or Angiography Guided De-escalation of DAPT","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":80,"lead_sponsor_name":"Shenyang Northern Hospital","has_results":false},{"nct_id":"NCT07024446","title":"Comparison of Cardiovascular Risks Between Hip Fracture Surgery With Continued DAPT（Dual Antiplatelet Therapy ） Within 6 Weeks vs After 6 Weeks Post-PCI（Percutaneous Coronary Intervention）: A Prospective Observational Cohort Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Fujian Medical University Union Hospital","has_results":false},{"nct_id":"NCT07238764","title":"OCT-based DAPT Cessation in HBR Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health","has_results":false},{"nct_id":"NCT07514962","title":"Minimally Invasive Coronary Artery Bypass Supported by Cangrelor","phase":"","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Cardiocentro Ticino","has_results":false},{"nct_id":"NCT03224923","title":"A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Ottawa Heart Institute Research Corporation","has_results":false}],"total":29},"guidelines":[],"source":"Drug Landscape verified database"}